MedTrace Logo

Eye Diseases "Treated" with Interoperable Medical Informatics

NCT06810011 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-02-05

No results posted yet for this study

Summary

The overarching goal of EyeMatics is to promote an interoperable, sustainable infrastructure for the integration and sharing of data from clinical research to improve personalized medicine in ophthalmology. To achieve this, EyeMatics bundles the expertise and preliminary work of the four consortia of the Medical Informatics Initiative (MII) and the ophthalmological centers of excellence in Germany. The perspective and concerns of patients will be strongly incorporated into the project work through close cooperation with patient representatives and the inclusion of patient feedback on quality of life and treatment success.

EyeMatics aims to improve the understanding of the therapeutic success of eye diseases that are usually treated with intravitreal surgical medication (IVOM). To this end, an exemplary analysis platform for "real" clinical data will be provided and a dashboard for data visualization and analysis will be developed as a web application. The dashboard is to be introduced at all participating hospital sites for research purposes.

Conditions

  • Intravitreal Injections

Sponsors & Collaborators

  • University Medicine Greifswald

    collaborator OTHER

  • University Medical Center Mainz

    collaborator OTHER

  • University Hospital, Aachen

    collaborator OTHER

  • Klinikum Chemnitz gGmbH

    collaborator OTHER

  • Technische Universität Dresden

    collaborator UNKNOWN

  • University of Leipzig

    collaborator OTHER

  • University Hospital Tuebingen

    collaborator OTHER

  • Deutsche Ophthalmologische Gesellschaft e.V.

    collaborator UNKNOWN

  • Pro Retina Deutschland e.V.

    collaborator UNKNOWN

  • University Hospital Muenster

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2028-02-29
Completion
2028-02-29

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06810011 on ClinicalTrials.gov